These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22067565)

  • 1. Inotropic support in the NICU: ever more compounds in search of guidance? Commentary on J. Esch et al.: differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation (Neonatology 2012;101:192–200) and M.P. De Carolis et al.: levosimendan in two neonates with ischemic heart failure and pulmonary hypertension (Neonatology 2012;101:201–205).
    Thewissen L; Allegaert K
    Neonatology; 2012; 101(3):206-9. PubMed ID: 22067565
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation.
    Esch J; Joynt C; Manouchehri N; Lee TF; Li YQ; Bigam D; Vento M; Cheung PY
    Neonatology; 2012; 101(3):192-200. PubMed ID: 22067461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension.
    De Carolis MP; Piastra M; Bersani I; Pardeo M; Stival E; Tempera A; Romagnoli C; Conti G; De Rosa G
    Neonatology; 2012; 101(3):201-5. PubMed ID: 22067520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan in regional myocardial ischemia.
    Pieske B
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):379-81. PubMed ID: 12656119
    [No Abstract]   [Full Text] [Related]  

  • 5. Levosimendan Prevents and Reverts Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension.
    Hansen MS; Andersen A; Holmboe S; Schultz JG; Ringgaard S; Simonsen U; Happé C; Bogaard HJ; Nielsen-Kudsk JE
    J Cardiovasc Pharmacol; 2017 Oct; 70(4):232-238. PubMed ID: 28640039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan.
    Kamath SR; Jaykumar I; Matha S
    Indian Pediatr; 2009 Jul; 46(7):593-6. PubMed ID: 19638658
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical support and surgery of the failing heart: levosimendan.
    Toller W; Knez I
    Scand J Surg; 2007; 96(2):121-4. PubMed ID: 17679353
    [No Abstract]   [Full Text] [Related]  

  • 9. [Levosimendan, a revolution in the world of inotropic agents?].
    Bonnefoy E; Trindade PT
    Rev Med Suisse; 2005 May; 1(21):1425-6, 1428-9. PubMed ID: 15997981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
    Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levosimendan--an alternative to conventional inotropic treatment of patients with acute heart failure?].
    Rasmussen T; Schmidt H
    Ugeskr Laeger; 2006 Jan; 168(3):261-5. PubMed ID: 16430807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan: a new option in acute cardiac failure.
    Holley AD; Ziegenfuss M
    Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of levosimendan in acute heart failure and its effect on renal function].
    Moyano AP; Hidalgo RL; Grande DB; Morales SC
    Nefrologia; 2009; 29(6):616-7. PubMed ID: 19936016
    [No Abstract]   [Full Text] [Related]  

  • 16. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
    Axelsson B; Johansson G; Abrahamsson P; Gupta A; Tydén H; Wouters P; Haney M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):719-28. PubMed ID: 23517167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan: perpetuum mobile?
    Agewall S; Atar D
    Eur Heart J; 2007 Feb; 28(4):515. PubMed ID: 17283001
    [No Abstract]   [Full Text] [Related]  

  • 18. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
    Wiklund A; Kylhammar D; Rådegran G
    J Cardiovasc Pharmacol; 2012 May; 59(5):441-9. PubMed ID: 22240915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levosimendan for treatment of heart failure].
    Yasumura Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380
    [No Abstract]   [Full Text] [Related]  

  • 20. Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.".
    Damman K; Voors AA
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):403-4. PubMed ID: 18030611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.